Related Experiment Video
Updated: May 20, 2026
10:20
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
Basic research in HIV vaccinology is hampered by reductionist thinking
1Stellenbosch Institute of Advanced Study, Wallenberg Research Center at Stellenbosch University, Stellenbosch, South Africa.
Frontiers in Immunology
|July 13, 2012
Summary
Structure-based reverse vaccinology for HIV-1 vaccines faces challenges due to immune system complexity. Current strategies, focusing on specific antibody targets, are unlikely to yield a broadly neutralizing HIV-1 vaccine.
Area of Science:
- Immunology
- Vaccine Development
- Structural Biology
Background:
- HIV-1 vaccine development faces significant hurdles.
- Reverse vaccinology aims to design immunogens based on structural information.
- Antibody polyspecificity and immune system complexity impact vaccine design.
Purpose of the Study:
- To review structure-based reverse vaccinology for HIV-1 vaccine development.
- To analyze the limitations of current approaches in inducing broadly neutralizing antibodies.
- To discuss the impact of reductionist thinking on HIV vaccine research.
Main Methods:
- Review of protein immunochemistry principles.
- Analysis of antibody polyspecificity.
- Evaluation of structure-based immunogen design strategies.
Main Results:
- Structure-based reverse vaccinology has not yet produced effective HIV-1 vaccine immunogens.
- Reductionist approaches, like focusing on single epitopes, have proven unsuccessful.
- The need for extensive antibody affinity maturation highlights limitations in current design strategies.
Conclusions:
- Reverse vaccinology is unlikely to lead to a preventive HIV-1 vaccine.
- Immune correlates of protection cannot be identified until an effective vaccine exists.
- Current strategies fail because they do not account for the naive immune system's B-cell receptor repertoire.
Keywords:
HIV vaccinesantibody affinity maturationantibody polyspecificitydiscontinuous protein epitopesrational vaccine designreductionismreverse vaccinologysystems biologyMore Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...